Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 18 Mar 2024 for Applied Therapeutics, Inc., €240k. Read the official filing
Filing timeline
BuySaleAdam Hansard
Insider track record
Disclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Adam Hansard: trading record in brief
Adam Hansard (senior executive) discloses dealings in Applied Therapeutics Inc. to SEC (Form 4). Over a trading history stretching from 26 May 2021 to 14 March 2024, the count stands at 9 filings.
Sales make up the whole of the open-market record (5 sales, €315k). Other entries cover 4 share grants. In 2024 alone, the filings show no purchases and 1 sale.
The newest entry dates from 18 March 2024: an open-market sale of €240k, in Applied Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Adam Hansard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
48,871 shares@ US$5.39100.0% of flowCommon StockSEC:0001096906-24-000493:0
400,000 shares0Common StockSEC:0001209191-23-059634:0
965 shares@ US$1.971.5% of flowCommon StockSEC:0001209191-23-057115:0
9,720 shares@ US$2.7021.6% of flowCommon StockSEC:0001209191-23-050890:0
4,495 shares@ US$0.913.2% of flowCommon StockSEC:0001209191-23-003288:0
31,700 shares0Common StockSEC:0001209191-22-002968:0
31,700 shares0Common StockSEC:0001209191-22-002964:0
31,700 shares0Common StockSEC:0001209191-21-070086:0
2,894 shares@ US$18.3558.8% of flowCommon StockSEC:0001209191-21-036685:0
9 of 9 declarations
